|Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.|
RS Warren, H Yuan, MR Matli, NA Gillett, N Ferrara
The Journal of clinical investigation 95 (4), 1789-1797, 1995
|Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis|
K Kinkel, Y Lu, M Both, RS Warren, RF Thoeni
Radiology 224 (3), 748-756, 2002
|Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy|
ST Pullarkat, J Stoehlmacher, V Ghaderi, YP Xiong, SA Ingles, A Sherrod, ...
The pharmacogenomics journal 1 (1), 65-70, 2001
|Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains: association with endothelial cell …|
D Guo, Q Jia, HY Song, RS Warren, DB Donner
Journal of Biological Chemistry 270 (12), 6729-6733, 1995
|Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B …|
MM Bertagnolli, D Niedzwiecki, CC Compton, HP Hahn, M Hall, B Damas, ...
Journal of clinical Oncology 27 (11), 1814, 2009
|Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction|
TE Godfrey, SH Kim, M Chavira, DW Ruff, RS Warren, JW Gray, ...
The Journal of molecular diagnostics 2 (2), 84-91, 2000
|Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)|
NE Kemeny, D Niedzwiecki, DR Hollis, HJ Lenz, RS Warren, ...
Journal of Clinical Oncology 24 (9), 1395-1403, 2006
|Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma|
RS Warren, H Yuan, MR Matli, N Ferrara, DB Donner
Journal of Biological Chemistry 271 (46), 29483-29488, 1996
|Tumor necrosis factor and the acute metabolic response to tissue injury in man.|
HF Starnes, RS Warren, M Jeevanandam, JL Gabrilove, W Larchian, ...
The Journal of clinical investigation 82 (4), 1321-1325, 1988
|Mutations of the PATCHED Gene in Several Types of Sporadic Extracutaneous Tumors|
J Xie, RL Johnson, X Zhang, JW Bare, FM Waldman, PH Cogen, ...
Cancer research 57 (12), 2369-2372, 1997
|β-Catenin regulates vascular endothelial growth factor expression in colon cancer|
V Easwaran, SH Lee, L Inge, L Guo, C Goldbeck, E Garrett, M Wiesmann, ...
Cancer research 63 (12), 3145-3153, 2003
|Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial|
S Mulvihill, R Warren, A Venook, A Adler, B Randlev, C Heise, D Kirn
Gene therapy 8 (4), 308-315, 2001
|Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation|
LW Wu, LD Mayo, JD Dunbar, KM Kessler, MR Baerwald, EA Jaffe, ...
Journal of Biological Chemistry 275 (7), 5096-5103, 2000
|The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer|
ME Lippman, JC Allegra, EB Thompson, R Simon, A Barlock, L Green, ...
New England Journal of Medicine 298 (22), 1223-1228, 1978
|Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis|
F Coll, J Phelan, GA Hill-Cawthorne, MB Nair, K Mallard, S Ali, ...
Nature genetics 50 (2), 307-316, 2018
|The acute metabolic effects of tumor necrosis factor administration in humans|
RS Warren, HF Starnes, JL Gabrilove, HF Oettgen, MF Brennan
Archives of Surgery 122 (12), 1396-1400, 1987
MA Tempero, JP Arnoletti, S Behrman, E Ben-Josef, AB Benson, JD Berlin, ...
Journal of the National Comprehensive Cancer Network 8 (9), 972-1017, 2010
|Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.|
PB Chapman, TJ Lester, ES Casper, JL Gabrilove, GY Wong, SJ Kempin, ...
Journal of Clinical Oncology 5 (12), 1942-1951, 1987
|Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy|
FA Sinicrope, MR Mahoney, TC Smyrk, SN Thibodeau, RS Warren, ...
Journal of clinical oncology 31 (29), 3664, 2013
|Intravascular adenoviral agents in cancer patients: lessons from clinical trials|
T Reid, R Warren, D Kirn
Cancer gene therapy 9 (12), 979-986, 2002